PRICE T ROWE ASSOCIATES INC /MD/ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$11,554
+7.3%
113,414
+6.3%
0.00%0.0%
Q2 2023$10,765
+20.0%
106,676
+9.4%
0.00%
+100.0%
Q1 2023$8,971
+5.4%
97,502
+3.9%
0.00%0.0%
Q4 2022$8,512
-99.9%
93,829
-0.8%
0.00%
-50.0%
Q3 2022$13,264,000
+279.2%
94,603
+128.6%
0.00%
Q2 2022$3,498,000
+0.9%
41,383
+4.8%
0.00%
Q1 2022$3,466,000
+15.8%
39,502
+15.5%
0.00%
Q4 2021$2,992,000
+9.8%
34,209
+2.7%
0.00%
Q3 2021$2,724,000
-2.5%
33,319
+8.8%
0.00%
Q2 2021$2,794,000
+18.6%
30,628
+11.1%
0.00%
Q1 2021$2,356,000
+13.1%
27,565
-2.4%
0.00%
Q4 2020$2,084,000
-96.2%
28,236
-95.5%
0.00%
-100.0%
Q3 2020$54,349,000
+133.7%
624,986
+134.7%
0.01%
+100.0%
Q2 2020$23,255,000
-28.9%
266,260
-32.9%
0.00%
-40.0%
Q1 2020$32,709,000
+275.2%
396,716
+331.0%
0.01%
+400.0%
Q4 2019$8,717,000
+256.5%
92,051
+227.2%
0.00%
Q3 2019$2,445,000
-10.6%
28,137
-6.0%
0.00%
Q2 2019$2,734,000
-3.5%
29,937
+1.6%
0.00%
Q1 2019$2,833,000
+12.3%
29,468
+0.3%
0.00%
Q4 2018$2,522,000
-14.9%
29,387
-14.5%
0.00%
Q3 2018$2,963,000
+10.6%
34,387
-3.1%
0.00%
Q2 2018$2,680,000
-14.5%
35,475
-8.5%
0.00%
Q1 2018$3,134,000
+20.5%
38,765
+25.2%
0.00%
Q4 2017$2,600,000
+50.7%
30,963
+54.1%
0.00%
Q3 2017$1,725,000
+2.5%
20,099
-0.3%
0.00%
Q2 2017$1,683,000
+12.4%
20,1590.0%0.00%
Q1 2017$1,497,000
-4.6%
20,159
-6.5%
0.00%
Q4 2016$1,570,000
-9.0%
21,549
-1.3%
0.00%
Q3 2016$1,725,000
+1.7%
21,841
+6.3%
0.00%
Q2 2016$1,696,000
+16.3%
20,551
+2.1%
0.00%
Q1 2016$1,458,000
-22.1%
20,121
-7.5%
0.00%
Q4 2015$1,872,000
-6.4%
21,7580.0%0.00%
Q3 2015$2,000,000
-94.4%
21,758
-94.0%
0.00%
-100.0%
Q2 2015$35,526,000
-1.3%
361,258
-1.1%
0.01%0.0%
Q1 2015$36,008,000
+8.2%
365,158
+1.6%
0.01%0.0%
Q4 2014$33,293,000
-2.7%
359,308
-1.2%
0.01%0.0%
Q3 2014$34,217,000
-66.6%
363,508
-67.8%
0.01%
-68.2%
Q2 2014$102,338,000
+7236.1%
1,130,428
+6789.5%
0.02%
Q1 2014$1,395,000
-47.1%
16,408
-50.0%
0.00%
Q4 2013$2,638,000
+111.0%
32,816
+101.3%
0.00%
Q3 2013$1,250,000
-46.3%
16,300
-50.5%
0.00%
Q2 2013$2,326,00032,9000.00%
Other shareholders
NOVARTIS A G shareholders Q4 2021
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders